The sodium/iodide symporter (NIS): molecular physiology and preclinical and clinical applications

S Ravera, A Reyna-Neyra, G Ferrandino… - Annual review of …, 2017 - annualreviews.org
Active iodide (I−) transport in both the thyroid and some extrathyroidal tissues is mediated by
the Na+/I− symporter (NIS). In the thyroid, NIS-mediated I− uptake plays a pivotal role in …

Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28

PN Le, JD McDermott, A Jimeno - Pharmacology & therapeutics, 2015 - Elsevier
The Wnt signaling pathways are a group of signal transduction pathways that play an
important role in cell fate specification, cell proliferation and cell migration. Aberrant …

Drugging Wnt signalling in cancer

P Polakis - The EMBO journal, 2012 - embopress.org
Aberrant regulation of the Wnt signalling pathway has emerged as a prevalent theme in
cancer biology. This chapter summarizes the research that provides a proof of concept for …

The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics

T Kogai, GA Brent - Pharmacology & therapeutics, 2012 - Elsevier
Expression of the sodium iodide symporter (NIS) is required for efficient iodide uptake in
thyroid and lactating breast. Since most differentiated thyroid cancer expresses NIS, β …

Current understanding on EGFR and Wnt/β-catenin signaling in glioma and their possible crosstalk

I Paul, S Bhattacharya, A Chatterjee… - Genes & …, 2013 - journals.sagepub.com
Glioblastoma multiformes (GBMs) are extensively heterogeneous at both cellular and
molecular levels. Current therapeutic strategies include targeting of key signaling molecules …

The biology of the sodium iodide symporter and its potential for targeted gene delivery

M Hingorani, C Spitzweg, G Vassaux… - Current cancer drug …, 2010 - ingentaconnect.com
The sodium iodide symporter (NIS) is responsible for thyroidal, salivary, gastric, intestinal
and mammary iodide uptake. It was first cloned from the rat in 1996 and shortly thereafter …

The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies

AR Penheiter, SJ Russell, SK Carlson - Current gene therapy, 2012 - ingentaconnect.com
Preclinical and clinical tomographic imaging systems increasingly are being utilized for non-
invasive imaging of reporter gene products to reveal the distribution of molecular …

Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer

Q Li, L Zhang, J Lang, Z Tan, Q Feng, F Zhu… - Advanced …, 2023 - Wiley Online Library
Restoring sodium iodide symporter (NIS) expression and function remains a major
challenge for radioiodine therapy in anaplastic thyroid cancer (ATC). For more efficient …

Epidermal growth factor receptor-targeted 131I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene

K Klutz, D Schaffert, MJ Willhauck, GK Grünwald… - Molecular therapy, 2011 - cell.com
We recently demonstrated tumor-selective iodide uptake and therapeutic efficacy of
radioiodine in neuroblastoma tumors after systemic nonviral polyplex-mediated sodium …

Mesenchymal stem cell–mediated, tumor stroma–targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene

K Knoop, N Schwenk, K Schmohl, A Müller… - Journal of Nuclear …, 2015 - Soc Nuclear Med
The tumor-homing property of mesenchymal stem cells (MSCs) allows targeted delivery of
therapeutic genes into the tumor microenvironment. The application of sodium iodide …